Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Genesco (GCO) Asset Writedowns and Impairment (2016 - 2026)

Genesco has reported Asset Writedowns and Impairment over the past 17 years, most recently at $478000.0 for Q1 2026.

For Q1 2026, Asset Writedowns and Impairment fell 46.29% year-over-year to $478000.0; the TTM value through Jan 2026 reached $4.4 million, up 216.04%, while the annual FY2026 figure was $4.4 million, 216.04% up from the prior year.
Asset Writedowns and Impairment for Q1 2026 was $478000.0 at Genesco, down from $3.9 million in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $3.9 million in Q4 2025 and troughed at $34000.0 in Q2 2025.
A 5-year average of $590428.6 and a median of $276000.0 in 2023 define the central range for Asset Writedowns and Impairment.
Biggest five-year swings in Asset Writedowns and Impairment: crashed 90.85% in 2022 and later skyrocketed 2782.09% in 2025.
Year by year, Asset Writedowns and Impairment stood at $129000.0 in 2022, then dropped by 23.26% to $99000.0 in 2023, then soared by 35.35% to $134000.0 in 2024, then skyrocketed by 2782.09% to $3.9 million in 2025, then tumbled by 87.62% to $478000.0 in 2026.
Business Quant data shows Asset Writedowns and Impairment for GCO at $478000.0 in Q1 2026, $3.9 million in Q4 2025, and $34000.0 in Q2 2025.